Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Clinicopathologic characteristics of 84 unresectable stage III non-small-cell lung cancer patients

From: FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy

Characteristic Patients
Age (y)  
Median, year (range) 70 (37–87)
Gender  
Male 55 (65.5%)
Female 29 (34.5%)
KPS  
Median (range) 90 (70–100)
Smoking history  
Yes 77 (91.7%)
No 7 (8.3%)
Histology  
Squamous 38 (45.2%)
Adenocarcinoma 34 (40.5%)
NSC NOS 12 (14.3%)
GTV  
Median, cm3 (range) 96.6 (4.1-753.2)
SUV1  
Median value (range) 14.2 (2.5-66)
Median time, month (range) 0.7 (0.1-2.7)
SUV2  
Median value (range) 3.6 (1.9-28.1)
Median time, month (range) 4.2 (0.8-6.0)
  1. Abbreviations: KPS = Karnofsky Performance Status; NSC NOS = non-small cell cancer and no otherwise specified; GTV = gross tumor volume; SUV = standardized uptake values.